Polomar Health Services, Inc. (PMHS): Total Liabilities
$1.61M
As of 2025-12-31
$1.87M
As of 2026-06-30
+178.4%
3-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.61M | +19.2% | 2026-05-06, Balance as of period end |
| 2024-12-31 | $1.35M | +792.0% | 2026-05-06, Balance as of period end |
| 2023-12-31 | $151.6K | +103.0% | 2025-05-22, Balance as of period end |
| 2022-12-31 | $74.7K | n/a | 2024-04-15, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Polomar Health Services, Inc. (PMHS) | 2025-12-31 | $1.61M | +19.2% |
| BioXcel Therapeutics, Inc. (BTAIQ) | 2025-12-31 | $140.38M | +6.8% |
| Vaccinex, Inc. (VCNX) | 2024-12-31 | $5.08M | -14.4% |
| Lexaria Bioscience Corp. (LEXX) | 2025-08-31 | $1.57M | +30.1% |
| PMGC Holdings Inc. (ELAB) | 2025-12-31 | $5.03M | +115.6% |
| Yarrow Bioscience, Inc. (YARW) | 2025-12-31 | $2.40M | -83.8% |
| Silence Therapeutics plc (SLN) | 2025-12-31 | $69.14M | +0.8% |
| Quantum Cyber N.V. (QUCY) | 2025-12-31 | $4.69M | -37.6% |
| Lipella Pharmaceuticals Inc. (LIPO) | 2024-12-31 | $754.4K | +74.3% |
Compare PMHS, BTAIQ, VCNX, LEXX side by side · Screen every company in Pharmaceutical Preparations ↗